Drug intelligence / Profile preview

ambrosia trifida pollen + ambrosia artemisiifolia pollen

Development stage
Unknown
Lead developer
Stallergenes Greer
Administration
Subcutaneous, Intradermal, Percutaneous
01

Overview

A **combination allergenic extract** composed of pollen from *Ambrosia trifida* and *Ambrosia artemisiifolia* used in allergen immunotherapy and diagnostic allergy testing for ragweed sensitization. This product is marketed as a non-standardized biologic allergen extract for **skin test diagnosis** in patients with a clinical history of ragweed allergy and, after dilution, for **subcutaneous immunotherapy**. Its therapeutic effect is based on controlled exposure to ragweed allergens to modulate the allergic immune response, while its diagnostic use relies on provoking an IgE-mediated hypersensitivity response in sensitized individuals. The product has been marketed by Greer Laboratories and is distinct from the approved sublingual short ragweed tablet product that contains only *Ambrosia artemisiifolia*.

Other names
short and giant ragweed pollen mixshort and giant ragweed pollen mix allergenic extractambrosia artemisiifolia and ambrosia trifida solution
02

Targets

A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)

Beyond the preview

Go deeper on ambrosia trifida pollen + ambrosia artemisiifolia pollen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ambrosia trifida pollen + ambrosia artemisiifolia pollen.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call